相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Combining On-Chip Synthesis of a Focused Combinatorial Library with Computational Target Prediction Reveals Imidazopyridine GPCR Ligands
Michael Reutlinger et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Accessing New Chemical Entities through Microfluidic Systems
Tiago Rodrigues et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Multi-Objective Molecular De Novo Design by Adaptive Fragment Prioritization
Michael Reutlinger et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Identifying the macromolecular targets of de novo-designed chemical entities through self-organizing map consensus
Daniel Reker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Drugs by Numbers: Reaction-Driven De Novo Design of Potent and Selective Anticancer Leads
Birgit Spaenkuch et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)
Steering Target Selectivity and Potency by Fragment-Based De Novo Drug Design
Tiago Rodrigues et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)
Colloidal Aggregation Causes Inhibition of G Protein-Coupled Receptors
Maria F. Sassano et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Chemically Advanced Template Search (CATS) for Scaffold-Hopping and Prospective Target Prediction for Orphan' Molecules
Michael Reutlinger et al.
MOLECULAR INFORMATICS (2013)
The past, present and potential for microfluidic reactor technology in chemical synthesis
Katherine S. Elvira et al.
NATURE CHEMISTRY (2013)
A pharmacological organization of G protein-coupled receptors
Henry Lin et al.
NATURE METHODS (2013)
De novo design and optimization of Aurora A kinase inhibitors
Tiago Rodrigues et al.
CHEMICAL SCIENCE (2013)
Automated design of ligands to polypharmacological profiles
Jeremy Besnard et al.
NATURE (2012)
Reducing safety-related drug attrition: the use of in vitro pharmacological profiling
Joanne Bowes et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
ChEMBL: a large-scale bioactivity database for drug discovery
Anna Gaulton et al.
NUCLEIC ACIDS RESEARCH (2012)
DOGS: Reaction-Driven de novo Design of Bioactive Compounds
Markus Hartenfeller et al.
PLOS COMPUTATIONAL BIOLOGY (2012)
Neighborhood-Preserving Visualization of Adaptive Structure-Activity Landscapes: Application to Drug Discovery
Michael Reutlinger et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2011)
Special Issue: Guide to Receptors and Channels, 5th Edition Abstracts
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Drug discovery in the next decade: innovation needed ASAP
Youssef L. Bennani
DRUG DISCOVERY TODAY (2011)
An Integrated Synthesis-Purification System to Accelerate the Generation of Compounds in Pharmaceutical Discovery
Jill E. Hochlowski et al.
JOURNAL OF FLOW CHEMISTRY (2011)
N-Tetrahydrothiochromenoisoxazole-1-carboxamides as selective antagonists of cloned human 5-HT2B
Yoon Jin Kwon et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Extended-Connectivity Fingerprints
David Rogers et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2010)
Design, Synthesis, and Structure-Affinity Relationships of Regioisomeric N-Benzyl Alkyl Ether Piperazine Derivatives as σ-1 Receptor Ligands
Iman A. Moussa et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
Jonathan B. Baell et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
PRX-08066, a Novel 5-Hydroxytryptamine Receptor 2B Antagonist, Reduces Monocrotaline-Induced Pulmonary Arterial Hypertension and Right Ventricular Hypertrophy in Rats
Stacy L. Porvasnik et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
The Expanded Biology of Serotonin
Miles Berger et al.
ANNUAL REVIEW OF MEDICINE (2009)
A new class of 5-HT2B antagonists possesses favorable potency, selectivity, and rat pharmacokinetic properties
Neil Moss et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
GPCR Theme Editorial
G. Milligan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
In vitro safety pharmacology profiling: what else beyond hERG?
Jacques Hamon et al.
FUTURE MEDICINAL CHEMISTRY (2009)
FAF-Drugs2: Free ADME/tox filtering tool to assist drug discovery and chemical biology projects
David Lagorce et al.
BMC BIOINFORMATICS (2008)
Network pharmacology: the next paradigm in drug discovery
Andrew L. Hopkins
NATURE CHEMICAL BIOLOGY (2008)
Principal component analysis differentiates the receptor binding profiles of three antipsychotic drug candidates from current antipsychotic drugs
Jos H. M. Lange et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Relating protein pharmacology by ligand chemistry
Michael J. Keiser et al.
NATURE BIOTECHNOLOGY (2007)
Aripiprazole has functionally selective actions at dopamine D-2 receptor-mediated signaling pathways
Jonathan D. Urban et al.
NEUROPSYCHOPHARMACOLOGY (2007)
An integrated in silico 3D model-driven discovery of a novel, potent, and selective amidosulfonamide 5-HT1A agonist (PRX-00023) for the treatment of anxiety and depression
Oren M. Becker et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
1-((S)-2-aminopropyl)-1H-indazol-6-ol:: A potent peripherally acting 5-HT2 receptor agonist with ocular hypotensive activity
JA May et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
分享论文
